Moneycontrol
SENSEX NIFTY
Advanced Enzyme Technologies Chairman's Speech > Engineering - Heavy > Chairman's Speech from Advanced Enzyme Technologies - BSE: 540025, NSE: ADVENZYMES
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > CHAIRMANS SPEECH - Advanced Enzyme Technologies

Advanced Enzyme Technologies

BSE: 540025|NSE: ADVENZYMES|ISIN: INE837H01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 17, 16:00
265.40
0
VOLUME 22,455
LIVE
NSE
Oct 17, 15:58
265.75
0.15 (0.06%)
VOLUME 110,226
Array
Chairman's Speech (Advanced Enzyme Technologies) Year : Mar '17

Dear Shareholders,

On behalf of the Board of Directors and the Management, I am very pleased to provide you the first financial report of your Company post the Initial Public Offering (IPO) and listing on the Indian Stock Exchanges on 1st August 2016. I would like to inform you that your company''s IPO received an overwhelming response and was oversubscribed by 82.06 times, creating a record. This happens to be the 5th best IPO of all times by any Indian company to date, as reported by Bloomberg. Heartiest Congratulations to all of you on achieving this great milestone !

At the onset, I would like to thank each and every shareholder for having shown utmost trust and confidence on the Company''s business model, management and business strategy. Today, your Company has a Global presence, with exports to more than 45 countries. Your Company is at the forefront of enzyme technology, and leverages Research and Development (R&D) to deliver high quality products worldwide. Through sustained efforts and investments in R&D over the past two decades, your Company has developed a strong portfolio of over 65 enzymes & robotics.

In spite of the significant challenges faced, your Company''s revenues and profitability track record has been remarkably strong in the last 5 years. I owe my gratitude to all our employees & associates for their continued dedication, commitment and loyalty, that has helped the Company overcome these difficult times.

In the year gone by, your Company has forayed decisively into Probiotics. Probiotics is a .7 billion market globally and the main applications are in Nutrition & Healthcare. In the past year, your Company has also acquired a 70% stake in Hyderabad based JC Biotech Private Limited. Through this acquisition, your Company has strengthened its presence in a key API Serratiopeptidase, and has also acquired competencies & capabilities that are complementary to its existing plants.

I am thankful, to each and every one of you, for having participated in our journey so far, and look forward to your continued support.

V.L. Rathi

Thanking you. Chairman

Source :
Quick Links for advancedenzymetechnologies
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.